CD7 was the most prevalent aberrant lymphoid antigen, as it was present in 26.5% of all cases and was more frequent in pediatric AML patients (28.2% vs. 25.9% of adult AML cases) [18]. This evidence concerns the gene CD7 and acute myeloid leukemia.